Loading…

Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor

The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2006-02, Vol.49 (3), p.864-871
Main Authors: Buchstaller, Hans-Peter, Siebert, Carsten D, Steinmetz, Ralf, Frank, Ina, Berger, Michael L, Gottschlich, Rudolf, Leibrock, Joachim, Krug, Michael, Steinhilber, Dieter, Noe, Christian R
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43
cites cdi_FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43
container_end_page 871
container_issue 3
container_start_page 864
container_title Journal of medicinal chemistry
container_volume 49
creator Buchstaller, Hans-Peter
Siebert, Carsten D
Steinmetz, Ralf
Frank, Ina
Berger, Michael L
Gottschlich, Rudolf
Leibrock, Joachim
Krug, Michael
Steinhilber, Dieter
Noe, Christian R
description The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the three possible thienopyridinone isomers. 4-Hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one (3a), with the shortest distance between the sulfur and the nitrogen atom, was the most potent isomer (K i against the binding of [3H]glycine to rat membranes 16 μM), comparable in potency to the model quinolinone (21, 12 μM). Replacement of the phenyl substituent of 21 by a 2-thienyl residue resulted in a 2−5-fold loss in potency and was abandoned. In the thieno part of the thienopyridinone nucleus, the most successful substituents were halogen (Cl or Br) close to the sulfur atom and short alkyl chains at the other position, resulting in 7h, 8h, 8i, and 8m, with K i values between 5.8 and 10.5 nM. Introduction of a 3‘-phenoxy moiety yielded several compounds with still higher potencies (18h, 18i, 18l, and 18m; K i between 1.1 and 2.0 nM). Quantitative structure−activity relationship (QSAR) calculations resulted in a consistent interpretation of the potencies of most compounds. Several of these 3‘-phenoxy derivatives protected mouse fibroblast cell lines with transfected NMDA receptors from glutamate-induced toxicity. In addition, we report in vivo results for four of these compounds.
doi_str_mv 10.1021/jm0503493
format article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_jm0503493</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>c506372748</sourcerecordid><originalsourceid>FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43</originalsourceid><addsrcrecordid>eNptkNtuEzEQhi0EoqHlghdAvkGiEi4-7ekyDdC06iGiQUhU1Wp8WOI08a5sV2Lfgwdm00TNDVcjzXzzzehH6B2jJ4xy9nm5phkVshIv0IhlnBJZUvkSjSjlnPCciwP0JsYlpVQwLl6jA5bLjNGMj9Df296nhY0u4rbB84Wzvr3jnwRR97M-OON8623EY52c_40h4kmf2i60yeoEPkUM3mza537hlEttePLcien92arXzlt86rzZ7KYWD4fwNbmyadGviCEQOwgJksUfr6--jI_xd6ttNziO0KsGVtG-3dVD9OPb1_lkSi5vzs4n40sCUhaJlJQaUQnBgXPbiJLlKmsaycsGKgZKgFGZVZyKrFKy0FYJkRtT5mAaK4aWOETHW68ObYzBNnUX3BpCXzNab5Ktn5Md2PdbtntUa2v25C7KAfiwAyBqWDUBvHZxzxWyymWx4ciWczHZP89zCA91Xogiq-ez23r682J6MZuc1r_2XtCxXraPwQ-R_OfBf9oFnDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Buchstaller, Hans-Peter ; Siebert, Carsten D ; Steinmetz, Ralf ; Frank, Ina ; Berger, Michael L ; Gottschlich, Rudolf ; Leibrock, Joachim ; Krug, Michael ; Steinhilber, Dieter ; Noe, Christian R</creator><creatorcontrib>Buchstaller, Hans-Peter ; Siebert, Carsten D ; Steinmetz, Ralf ; Frank, Ina ; Berger, Michael L ; Gottschlich, Rudolf ; Leibrock, Joachim ; Krug, Michael ; Steinhilber, Dieter ; Noe, Christian R</creatorcontrib><description>The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the three possible thienopyridinone isomers. 4-Hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one (3a), with the shortest distance between the sulfur and the nitrogen atom, was the most potent isomer (K i against the binding of [3H]glycine to rat membranes 16 μM), comparable in potency to the model quinolinone (21, 12 μM). Replacement of the phenyl substituent of 21 by a 2-thienyl residue resulted in a 2−5-fold loss in potency and was abandoned. In the thieno part of the thienopyridinone nucleus, the most successful substituents were halogen (Cl or Br) close to the sulfur atom and short alkyl chains at the other position, resulting in 7h, 8h, 8i, and 8m, with K i values between 5.8 and 10.5 nM. Introduction of a 3‘-phenoxy moiety yielded several compounds with still higher potencies (18h, 18i, 18l, and 18m; K i between 1.1 and 2.0 nM). Quantitative structure−activity relationship (QSAR) calculations resulted in a consistent interpretation of the potencies of most compounds. Several of these 3‘-phenoxy derivatives protected mouse fibroblast cell lines with transfected NMDA receptors from glutamate-induced toxicity. In addition, we report in vivo results for four of these compounds.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm0503493</identifier><identifier>PMID: 16451052</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Binding, Competitive ; Biological and medical sciences ; Blood-Brain Barrier - metabolism ; Cell Line ; Cytoprotection ; Electroshock ; Glutamatergic system (aspartate and other excitatory aminoacids) ; Glycine - metabolism ; Glycine - toxicity ; Humans ; In Vitro Techniques ; Male ; Medical sciences ; Mice ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; Protein Subunits - antagonists &amp; inhibitors ; Protein Subunits - genetics ; Protein Subunits - metabolism ; Pyridones - chemical synthesis ; Pyridones - chemistry ; Pyridones - pharmacology ; Quantitative Structure-Activity Relationship ; Radioligand Assay ; Rats ; Rats, Wistar ; Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors ; Receptors, N-Methyl-D-Aspartate - genetics ; Receptors, N-Methyl-D-Aspartate - metabolism ; Recombinant Proteins - antagonists &amp; inhibitors ; Recombinant Proteins - genetics ; Recombinant Proteins - metabolism ; Seizures - etiology ; Seizures - prevention &amp; control ; Thiophenes - chemistry ; Transfection</subject><ispartof>Journal of medicinal chemistry, 2006-02, Vol.49 (3), p.864-871</ispartof><rights>Copyright © 2006 American Chemical Society</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43</citedby><cites>FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17496472$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16451052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buchstaller, Hans-Peter</creatorcontrib><creatorcontrib>Siebert, Carsten D</creatorcontrib><creatorcontrib>Steinmetz, Ralf</creatorcontrib><creatorcontrib>Frank, Ina</creatorcontrib><creatorcontrib>Berger, Michael L</creatorcontrib><creatorcontrib>Gottschlich, Rudolf</creatorcontrib><creatorcontrib>Leibrock, Joachim</creatorcontrib><creatorcontrib>Krug, Michael</creatorcontrib><creatorcontrib>Steinhilber, Dieter</creatorcontrib><creatorcontrib>Noe, Christian R</creatorcontrib><title>Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the three possible thienopyridinone isomers. 4-Hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one (3a), with the shortest distance between the sulfur and the nitrogen atom, was the most potent isomer (K i against the binding of [3H]glycine to rat membranes 16 μM), comparable in potency to the model quinolinone (21, 12 μM). Replacement of the phenyl substituent of 21 by a 2-thienyl residue resulted in a 2−5-fold loss in potency and was abandoned. In the thieno part of the thienopyridinone nucleus, the most successful substituents were halogen (Cl or Br) close to the sulfur atom and short alkyl chains at the other position, resulting in 7h, 8h, 8i, and 8m, with K i values between 5.8 and 10.5 nM. Introduction of a 3‘-phenoxy moiety yielded several compounds with still higher potencies (18h, 18i, 18l, and 18m; K i between 1.1 and 2.0 nM). Quantitative structure−activity relationship (QSAR) calculations resulted in a consistent interpretation of the potencies of most compounds. Several of these 3‘-phenoxy derivatives protected mouse fibroblast cell lines with transfected NMDA receptors from glutamate-induced toxicity. In addition, we report in vivo results for four of these compounds.</description><subject>Animals</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Cell Line</subject><subject>Cytoprotection</subject><subject>Electroshock</subject><subject>Glutamatergic system (aspartate and other excitatory aminoacids)</subject><subject>Glycine - metabolism</subject><subject>Glycine - toxicity</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Subunits - antagonists &amp; inhibitors</subject><subject>Protein Subunits - genetics</subject><subject>Protein Subunits - metabolism</subject><subject>Pyridones - chemical synthesis</subject><subject>Pyridones - chemistry</subject><subject>Pyridones - pharmacology</subject><subject>Quantitative Structure-Activity Relationship</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><subject>Receptors, N-Methyl-D-Aspartate - genetics</subject><subject>Receptors, N-Methyl-D-Aspartate - metabolism</subject><subject>Recombinant Proteins - antagonists &amp; inhibitors</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - metabolism</subject><subject>Seizures - etiology</subject><subject>Seizures - prevention &amp; control</subject><subject>Thiophenes - chemistry</subject><subject>Transfection</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNptkNtuEzEQhi0EoqHlghdAvkGiEi4-7ekyDdC06iGiQUhU1Wp8WOI08a5sV2Lfgwdm00TNDVcjzXzzzehH6B2jJ4xy9nm5phkVshIv0IhlnBJZUvkSjSjlnPCciwP0JsYlpVQwLl6jA5bLjNGMj9Df296nhY0u4rbB84Wzvr3jnwRR97M-OON8623EY52c_40h4kmf2i60yeoEPkUM3mza537hlEttePLcien92arXzlt86rzZ7KYWD4fwNbmyadGviCEQOwgJksUfr6--jI_xd6ttNziO0KsGVtG-3dVD9OPb1_lkSi5vzs4n40sCUhaJlJQaUQnBgXPbiJLlKmsaycsGKgZKgFGZVZyKrFKy0FYJkRtT5mAaK4aWOETHW68ObYzBNnUX3BpCXzNab5Ktn5Md2PdbtntUa2v25C7KAfiwAyBqWDUBvHZxzxWyymWx4ciWczHZP89zCA91Xogiq-ez23r682J6MZuc1r_2XtCxXraPwQ-R_OfBf9oFnDg</recordid><startdate>20060209</startdate><enddate>20060209</enddate><creator>Buchstaller, Hans-Peter</creator><creator>Siebert, Carsten D</creator><creator>Steinmetz, Ralf</creator><creator>Frank, Ina</creator><creator>Berger, Michael L</creator><creator>Gottschlich, Rudolf</creator><creator>Leibrock, Joachim</creator><creator>Krug, Michael</creator><creator>Steinhilber, Dieter</creator><creator>Noe, Christian R</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20060209</creationdate><title>Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor</title><author>Buchstaller, Hans-Peter ; Siebert, Carsten D ; Steinmetz, Ralf ; Frank, Ina ; Berger, Michael L ; Gottschlich, Rudolf ; Leibrock, Joachim ; Krug, Michael ; Steinhilber, Dieter ; Noe, Christian R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Cell Line</topic><topic>Cytoprotection</topic><topic>Electroshock</topic><topic>Glutamatergic system (aspartate and other excitatory aminoacids)</topic><topic>Glycine - metabolism</topic><topic>Glycine - toxicity</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Subunits - antagonists &amp; inhibitors</topic><topic>Protein Subunits - genetics</topic><topic>Protein Subunits - metabolism</topic><topic>Pyridones - chemical synthesis</topic><topic>Pyridones - chemistry</topic><topic>Pyridones - pharmacology</topic><topic>Quantitative Structure-Activity Relationship</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</topic><topic>Receptors, N-Methyl-D-Aspartate - genetics</topic><topic>Receptors, N-Methyl-D-Aspartate - metabolism</topic><topic>Recombinant Proteins - antagonists &amp; inhibitors</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - metabolism</topic><topic>Seizures - etiology</topic><topic>Seizures - prevention &amp; control</topic><topic>Thiophenes - chemistry</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buchstaller, Hans-Peter</creatorcontrib><creatorcontrib>Siebert, Carsten D</creatorcontrib><creatorcontrib>Steinmetz, Ralf</creatorcontrib><creatorcontrib>Frank, Ina</creatorcontrib><creatorcontrib>Berger, Michael L</creatorcontrib><creatorcontrib>Gottschlich, Rudolf</creatorcontrib><creatorcontrib>Leibrock, Joachim</creatorcontrib><creatorcontrib>Krug, Michael</creatorcontrib><creatorcontrib>Steinhilber, Dieter</creatorcontrib><creatorcontrib>Noe, Christian R</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buchstaller, Hans-Peter</au><au>Siebert, Carsten D</au><au>Steinmetz, Ralf</au><au>Frank, Ina</au><au>Berger, Michael L</au><au>Gottschlich, Rudolf</au><au>Leibrock, Joachim</au><au>Krug, Michael</au><au>Steinhilber, Dieter</au><au>Noe, Christian R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2006-02-09</date><risdate>2006</risdate><volume>49</volume><issue>3</issue><spage>864</spage><epage>871</epage><pages>864-871</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>The standard glycine site antagonist of the N-methyl-d-aspartate (NMDA) receptor, 3-phenyl-4-hydroxyquinolin-2(1H)-one (21), was used as a template for bioisostere benzene/thiophene exchange. Phenylacetylation of aminothiophene carboxylic acid methyl esters and subsequent cyclization delivered the three possible thienopyridinone isomers. 4-Hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one (3a), with the shortest distance between the sulfur and the nitrogen atom, was the most potent isomer (K i against the binding of [3H]glycine to rat membranes 16 μM), comparable in potency to the model quinolinone (21, 12 μM). Replacement of the phenyl substituent of 21 by a 2-thienyl residue resulted in a 2−5-fold loss in potency and was abandoned. In the thieno part of the thienopyridinone nucleus, the most successful substituents were halogen (Cl or Br) close to the sulfur atom and short alkyl chains at the other position, resulting in 7h, 8h, 8i, and 8m, with K i values between 5.8 and 10.5 nM. Introduction of a 3‘-phenoxy moiety yielded several compounds with still higher potencies (18h, 18i, 18l, and 18m; K i between 1.1 and 2.0 nM). Quantitative structure−activity relationship (QSAR) calculations resulted in a consistent interpretation of the potencies of most compounds. Several of these 3‘-phenoxy derivatives protected mouse fibroblast cell lines with transfected NMDA receptors from glutamate-induced toxicity. In addition, we report in vivo results for four of these compounds.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>16451052</pmid><doi>10.1021/jm0503493</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2006-02, Vol.49 (3), p.864-871
issn 0022-2623
1520-4804
language eng
recordid cdi_crossref_primary_10_1021_jm0503493
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Animals
Binding, Competitive
Biological and medical sciences
Blood-Brain Barrier - metabolism
Cell Line
Cytoprotection
Electroshock
Glutamatergic system (aspartate and other excitatory aminoacids)
Glycine - metabolism
Glycine - toxicity
Humans
In Vitro Techniques
Male
Medical sciences
Mice
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
Protein Subunits - antagonists & inhibitors
Protein Subunits - genetics
Protein Subunits - metabolism
Pyridones - chemical synthesis
Pyridones - chemistry
Pyridones - pharmacology
Quantitative Structure-Activity Relationship
Radioligand Assay
Rats
Rats, Wistar
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Receptors, N-Methyl-D-Aspartate - genetics
Receptors, N-Methyl-D-Aspartate - metabolism
Recombinant Proteins - antagonists & inhibitors
Recombinant Proteins - genetics
Recombinant Proteins - metabolism
Seizures - etiology
Seizures - prevention & control
Thiophenes - chemistry
Transfection
title Synthesis of Thieno[2,3-b]Pyridinones Acting as Cytoprotectants and as Inhibitors of [3H]Glycine Binding to the N-Methyl-d-aspartate (NMDA) Receptor
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A00%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20Thieno%5B2,3-b%5DPyridinones%20Acting%20as%20Cytoprotectants%20and%20as%20Inhibitors%20of%20%5B3H%5DGlycine%20Binding%20to%20the%20N-Methyl-d-aspartate%20(NMDA)%20Receptor&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Buchstaller,%20Hans-Peter&rft.date=2006-02-09&rft.volume=49&rft.issue=3&rft.spage=864&rft.epage=871&rft.pages=864-871&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm0503493&rft_dat=%3Cacs_cross%3Ec506372748%3C/acs_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a447t-800d39332a22ef3816b5ff428fa91ab3adb5eb20359b47ceb336dd86adfe39b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/16451052&rfr_iscdi=true